Cargando…
Quantitative assessment of the associations between XRCC1 polymorphisms and bladder cancer risk
BACKGROUND: The XRCC1 polymorphisms have been implicated in bladder cancer risk, but individually published studies show inconsistent results. The aim of our study was to clarify the effects of XRCC1 variants on bladder cancer risk. METHODS: A systematic literature search up to September 13, 2012 wa...
Autores principales: | Mao, Yeqing, Xu, Xin, Lin, Yiwei, Chen, Hong, Wu, Jian, Hu, Zhenghui, Zhu, Yi, Xu, Xianglai, Xie, Liping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601005/ https://www.ncbi.nlm.nih.gov/pubmed/23496911 http://dx.doi.org/10.1186/1477-7819-11-58 |
Ejemplares similares
-
Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells
por: Zhu, Yi, et al.
Publicado: (2013) -
Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies
por: Xu, Xin, et al.
Publicado: (2013) -
MicroRNA-124-3p inhibits cell migration and invasion in bladder cancer cells by targeting ROCK1
por: Xu, Xianglai, et al.
Publicado: (2013) -
PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis
por: XU, XIN, et al.
Publicado: (2012) -
Up-regulation of p16 by miR-877-3p inhibits proliferation of bladder cancer
por: Li, Shiqi, et al.
Publicado: (2016)